Pharmacological Approach to Improve the Outcome of Social Cognition Training
Status:
Completed
Trial end date:
2013-02-01
Target enrollment:
Participant gender:
Summary
This study will evaluate whether oxytocin will facilitate the learning of social cognitive
skills in schizophrenia patients who receive 12 sessions of Social Cognitive Skills Training
(SCST). The primary hypothesis is that schizophrenia subjects who are treated with oxytocin
will demonstrate greater improvements in a summary measure of social cognition than subjects
treated with placebo over the course of SCST.
Phase:
Phase 1
Details
Lead Sponsor:
VA Greater Los Angeles Healthcare System
Collaborator:
National Alliance for Research in Schizophrenia and Affective Disorders